OH
Organogenesis Holdings Inc
🇺🇸XNAS.ORGOUnited StatesHealthcare
$1.41USDdown -0.04 (-2.76%)OpenDelayed5:10 PM
Price$1.41-0.04 (-2.76%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US68621F1021
- CUSIP
- 68621F102
Company
- Employees
- 854
- Headquarters
- Canton, United States
- Website
- https://organogenesis.com
- CEO
- Mr. Gary S. Gillheeney Sr.
Market
- Shares outstanding
- 128.7M
- Market cap
- $181.43M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $190.44M
- EPS LTM
- -$0.70
- P/E LTM
- -3.31
- Div yield
- 2.95%
Fundamentals (LTM)
- Revenue
- $456.54M+6.34%up year on year
- Net income
- -$90.23M-996.23%down year on year
- Gross margin
- 67.59%-9.36%down year on year
- Free cash flow
- $20.84M+144.94%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.